Role of biosimilars in neutropenia prevention in cancer patients

Authors: Ptushkin V.V.¹
Affiliations:
1. Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev, Ministry of Health of Russia, Moscow
Issue: Vol 9, No 3 (2014)
Pages: 41-46
Section: PHARMACOTHERAPY
Published: 30.10.2014
URL: https://oncohematology.abvpress.ru/ongm/article/view/122
DOI: https://doi.org/10.17650/1818-8346-2014-9-3-41-46
ID: 122

Cite item

Full Text

chemotherapy, neutropenia, granulocyte colony stimulating factor, biosimilars, Zarsio

Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev, Ministry of Health of Russia, Moscow

Author for correspondence.
Email: vadimvadim@inbox.ru
Russian Federation

Supplementary Files

Action

1. JATS XML